SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• SLC6A14 (ATB^0,+) is a sodium- and chloride-dependent amino acid transporter.
• It is overexpressed in human cancers, making it a potential therapeutic target.
• Limited knowledge exists regarding its molecular transport mechanism.

Purpose of the Study:

• To elucidate the molecular mechanism of SLC6A14 transport.
• To identify critical amino acid residues for substrate recognition and translocation.
• To provide insights for developing novel SLC6A14 inhibitors for cancer treatment.

Main Methods:

• Homology modeling to construct an outward-facing SLC6A14 model.
• Molecular dynamics simulations to predict critical residues.
• Molecular docking of amino acids and substrates to study binding sites and gating regions.

Main Results:

• Identified amino acid residues critical for substrate recognition and translocation.
• Some identified residues are conserved in related LeuT-fold transporters.
• A novel residue with a significant role in transport was discovered.

Conclusions:

• The study highlights the potential role of identified residues in neutral amino acid transport.
• Novel insights into the SLC6A14 structure-function relationship were revealed.
• Findings may aid in designing targeted cancer therapies by inhibiting SLC6A14-mediated transport.